PPP 784 DURICEF 500 mg (Duricef 500 mg)
Generic Name: cefadroxil
Pill imprint PPP 784 DURICEF 500 mg has been identified as Duricef 500 mg.
Duricef is used in the treatment of skin and structure infection; kidney infections; upper respiratory tract infection; urinary tract infection; tonsillitis/pharyngitis (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Duricef 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PPP 784 DURICEF 500 mg (Duricef 500 mg)
- Generic Name:
- cefadroxil
- Imprint:
-
PPP 784
DURICEF 500 mg - Strength:
- 500 mg
- Color:
- Red / White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- First generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
More resources
Duricef is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
